News

August 9, 2018: In The Know

August 8, 2018 | Tags: Anser Innovation, Bio-Techne, Boston Scientific, Cantel Medical, Envoy Medical, Featured, Global Kinetics, Impleo Medical, LivaNova, Mayo Clinic, Nexgen Medical Systems, Respicardia, Tactile Medical, UEL

Boston Scientific acquires remainder of vein stent maker Veniti in $160M deal

Cantel Medical pays $17m for Stericycle’s clean room biz

First and Only: Fully Implanted Esteem® Hearing Device Receives FDA Approval for MR-Conditional Labeling at Both 1.5 and 3.0 Tesla

University Enterprise Labs’ new leader on bringing coworking space energy to the laboratory

How ablation destroys cancer to prolong lives

Global Kinetics Corporation’s Personal KinetiGraph™ Welcomes New Category III CPT® Codes for Use in Parkinson’s Care

Anser Innovation Appoints Healthcare Veterans in Preparation For Ōmcare™ Launch

The 10 most innovative medical devices of 2018

MedTech Innovator Announces 50 Leading Startups Selected for 2018 Showcase and Accelerator

CMS Grants New Technology Add-on Payment to the remedē® System for the Treatment of Central Sleep Apnea

LivaNova Looking to Be a Standout Firm in TMVR

NextGen Medical targets clots in large vessels

Bio-Techne Releases Fourth Quarter Fiscal 2018 Results

Tactile Medical Announces Chief Financial Officer Transition

August 2, 2018: In The Know

August 1, 2018 | Tags: Abbott, Ativa Medical, Boston Scientific, Flywheel, Health Conference, MANOVA, Mayo Clinic, Medtronic, Praestan Health, Star Tribune, University of Minnesota

Behavioral-health startup Praestan raises $12 million

Boston Scientific-Backed gBeta Accelerator Picks 6 New Startups

Abbott’s Freestyle Libre 14 Day Flash Glucose Monitoring System Now Approved in U.S.

Mouse Engineered at UMN Brings in $1 Million

New Speakers Announced for Inaugural Global Health Conference

Breakthroughs in Portable Diagnostic Tests to Be Presented in a Special Competition at the 70th AACC Annual Scientific Meeting

Flywheel and Google Partner to Deliver Industry’s First Cloud-based MRI Research Center at Columbia University

The Future of Abbott’s Electrophysiology Business

Masonic Cancer Center, University of Minnesota Receives ‘Outstanding’ Rating from the National Cancer Institute

Medicalchain partners with the Mayo Clinic

Medtronic Announces Paurvi Bhatt as President of Medtronic Foundation

July 26, 2018: In The Know

July 26, 2018 | Tags: 3M, Be The Match, Bio-Techne, Boston Scientific, DMC, gBETA, Hitch Health, Magstim, Microbiologics, NeuroOne, Pace Analytical Life Sciences, Summit Medical, University of Minnesota, Vergent Bioscience

This Man Rewrites the Genetic Code of Animals

Gener8tor Announced the Newest Startups in its gBETA Medtech Accelerator

U of M Seeks to License New Algorithm Predicting Mortality Risks for Seriously Ill Patients

Hitch Health and Lyft Demonstrate Significant Reduction in Missed Medical Appointments

Boston Scientific Announces Results For Second Quarter 2018

3M delivers strong second quarter, beating expectations

Rochester development hits its stride

Microbiologics Expands Its Molecular Diagnostics QC Offering

Mayo-Backed Medtech Startup NeuroOne Seeking $10M

LI-COR and Vergent Establish Manufacturing Relationship

Pace Analytical quietly grew over 40 years to be one of America’s largest environmental labs

Top Industry Stakeholders Gather for Standardization Summit

Bio-Techne Introduces New Member of the Simple Western™ Family, with IR/NIR Detection Capabilities

Magstim Horizon Performance pioneering depression therapy product receives CE mark

Minne Ties® Agile MMF by Summit Medical Wins 2018 Medical Design Excellence Award

July 19, 2018: In The Know

July 19, 2018 | Tags: Abbott, Alska, Bio-Techne, Bright Health, CHF Solutions, Humanetics, Inspire Medical Systems, MANOVA, Medibio, Miromatrix, Pelican BioThermal, Physiq, Relievant Medsystems, Soundly, Tamarack Habilitation Technologies, Vyriad, Zipnosis

Implantable Organ Developer Miromatrix Medical Raises $15.7M

Minnesota health tech company accepted to world’s largest tech incubator, Station F in Paris

Relievant Announces First Commercial Intracept Procedures

Abbott Receives FDA Approval for Next-Generation MitraClip® Device To Treat People With Leaky Heart Valves

Inspire Medical CEO on going public, ramping up growth and ringing the stock-exchange bell

Vyriad Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Oncolytic Virus, Voyager-V1, in Combination with Anti-PD-L1 Antibody, Avelumab, in Phase 1 Clinical Study for Metastatic Colorectal Cancer

Netherlands-based Haga Teaching Hospital partners with physIQ and VitalConnect to continuously monitor cancer patients during treatment

Bright Health to expand its Obamacare footprint in 9 new markets

Why convergence is part of the future of healthcare

Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets

Trio of Minnesota Stem Cell Startups Receive State-Funded Commercialization Grants

CHF Solutions enters the German marketplace

Medibio Submits FDA De Novo Application

Pelican BioThermal Announces Availability of its New CoolPall™ Flex Bulk Shipper System

How the Didgeridoo and Physical Therapy Inspired a Local Sleep Startup

Med Tech Company Launches Clothing Line That Protects The Skin Of “Butterfly” Children (tamarak)

Humanetics Awarded Patent for Oral Drug to Protect Warfighters and First Responders from Radiation Exposure

Zipnosis Earns Surescripts® Certification to Strengthen Physician Workflows and Enhance Physician Experience

July 12, 2018: In The Know

July 10, 2018 | Tags: 3M, Advamed, Ambient Clinical Analytics Technology, Blue Cross and Blue Shield of Minnesota, Boston Scientific, Covr Medical, Hitch Health, Mayo Clinic, Medtronic, Pursuit Vascular, Relievant Medsystems

Relievant Medsystems settles into Twin Cities, sees big promise for back treatment

Medtronic touts one-year data from insulin pump study

Boston Scientific to Acquire Cryterion Medical, Inc.

Hitch Health raises $900K for health care ride-sharing

Blue Cross taps Anthem exec as new CEO

Mayo Spin-Off Ambient Clinical Analytics Eyes Euro Markets with Dutch Backer

Med-tech trade group takes aim at device tax

New survey finds infection preventionists want updated technology and processes to help fight HAI

Precision genomics point the way to mutations associated with accelerated aging

COVR Medical Announces Distribution Agreement With Owens & Minor

Medtronic takes on risk in payer and employer contracts tied to insulin pump use

Proposed Tariffs on Chinese Goods Take Effect

Pursuit Vascular Achieves Milestone with Shipment of 2 Millionth Pair of ClearGuard® HD Caps

June 28, 2018: In The Know

June 27, 2018 | Tags: Abbott, Bio-Techne, Blue Cross and Blue Shield of Minnesota, Ecolab, Lite Run, Medtronic, Microbiologics, Tactile Medical, Upsher-Smith, Urotronic

Abbott launches program to offset employee student loan debt

Prospect of China trade war sends chill through Minnesota med-tech

Bio-Techne buying ‘liquid biopsy’ firm Exosome for $250M+

Ecolab introduces tool to help reduce hospital infections

Tactile Medical Announces New Clinical Publication Demonstrating the Health and Economic Benefits of Flexitouch for Chronic Venous Insufficiency-related Lymphedema, Compared to Other Treatment Modalities

Chief medical officers at UnitedHealthcare, Blue Cross of MN have advice for med-tech companies

Space Suit Technology Helping Patients Walk Again

Upsher-Smith Wins Silver Stevie® at 2018 American Business Awards®

Medtronic, Abbott push new diabetes monitoring systems

Raffaella Giardino Joins Microbiologics, Inc. as Executive Director, International Sales

Urotronic’s Innovative Optilume™ Drug-Coated Balloon Catheter Receives License For Urethral Stricture Treatments in Canada

4C Medical Advances the State of the Heart

| Tags: 4C Medical Technologies, AltaValve, Angel Investor Tax Credit, Member, MR, News

4C Medical Technologies, Inc. (4C Medical), named after the four chambers of the heart, is developing a novel, minimally invasive device for the treatment of mitral regurgitation (MR). MR impacts up to 10 percent of people over age 75, half of whom are not eligible for open-heart surgery. The need for a minimally invasive solution and the growing addressable population have driven both increased investment and innovation in minimally invasive solutions.

4C Medical has developed a novel transcatheter MR treatment device, the AltaValve™. Unlike other transcatheter mitral valve replacement (TMVR) devices, AltaValve is placed in the left atrium, thus preserving left ventricle. Furthermore, due to supra-annular positioning of the valve, AltaValve avoids issues related to the complexity and dynamics of the mitral annulus, making it suitable for patients’ independent of their MR mechanism. This approach may eliminate complications that are associated with current TMVR devices, such as Left Ventricular Outflow Tract obstruction, device embolization, and early device fatigue failure.

AltaValve can be delivered using either a transapical or a transseptal delivery system.

Philippe Généreux, MD, Co-Director of the Structural Heart Program at the Gagnon Cardiovascular Institute of Morristown Medical Center in Morristown, New Jersey and a practicing Interventional Cardiologist at Hôpital du Sacré-Coeur de Montréal in Montreal, Quebec, Canada said of the AltaValve, “Delivered transseptally, this device will provide a treatment option for a broad MR patient population. This includes patients that can be treated by other TMVR devices, patients that cannot be treated by other TMVR devices, and even patients with previously failed mitral repair.”

4C raised $3 million through the Angel Investor Tax Credit and almost $9 million in total capital. When asked if this would have been harder without the credit, CEO Bob Thatcher remarked, “Absolutely! We were sorry to see the program was not extended into 2018, hopefully it will come back in the future to help startup companies like 4C Medical.”

Starting with the hiring of their first employee in mid-2016, the company has grown to 15 employees. Growth should continue, reaching to 40-50 employees over the next two years. “The angel tax credit was very beneficial to 4C Medical,” said Thatcher.

Growth has resulted from 4C Medical’s efficient operations: The team, experienced working in small cardiovascular companies, balances expertise to solve problems and ability to work fast with limited budgets. This maximizes innovation while minimizing wasted energy.

“The uniqueness of the device concept, combined with our exceptional and unified team, continues to lead to tremendous progress” stated Mr. Thatcher.